Logo

Senate Gives Trump Big Win as Senate Confirms Several Nominees

The Republican-controlled U.S. Senate approved three ambassadors appointed by President Donald Trump, stationing them in the United Kingdom, Turkey, and Italy, respectively. All three new ambassadors, Warren Stephens, Tom Barrack, and Tilman Feritta, have been vocal publicly about their support for Trump.

The Senate approved Stephens as the new ambassador to the United Kingdom and Northern Ireland by a vote of 59-39.

Arkansas GOP Sen. Tom Cotton spoke in favor of Stephens, an investment banker from his home state, describing him as a “family man, businessman, philanthropist, and patriot.”

“He is the right person to lead our strong, special relationship with the United Kingdom,” Cotton said.

Stephens served as president and CEO of Stephens Inc., a Little Rock-based investment banking business, until January.

According to Federal Election Commission records, Stephens donated $1 million to “Our Principles PAC,” a nonprofit that opposed Trump’s first presidential campaign.

 

However, he donated to Trump-aligned entities in 2019 and 2020, and in 2024, he gave $3 million to MAGA Inc., the primary Super PAC that supported Trump, according to FEC records.

“Warren has always dreamed of serving the United States full-time. I am thrilled that he will now have that opportunity as the top diplomat, representing the U.S.A. to one of America’s most cherished and beloved allies,” Trump said.

The Senate confirmed Barrack, a private equity executive and longtime Trump ally, in a 60-36 vote.

Barrack has known Trump since the 1980s. He worked in the Reagan administration before establishing the private equity company Colony Capital. He advised Trump’s campaign in 2016 and led his 2017 inauguration committee.

The Department of Justice accused Barrack in July 2021 of allegations of working as an unregistered lobbyist for the UAE. He denied any involvement and was acquitted in November 2022.

The Senate voted 83-14 to approve Fertitta as the United States ambassador to Italy.

 

Fertitta, whom Trump appointed to the position in December last year, is the CEO of Landry’s, a hospitality corporation that operates restaurants, hotels, casinos, and other entertainment facilities. He also owns the NBA team Houston Rockets.

This comes as Senate Republicans have confirmed over 100 of President Trump’s nominees, clearing the backlog of pending appointments in a single move.

The confirmations came after the Senate GOP changed its rules last month to allow most executive branch nominees to be approved en masse rather than individually.

The change does not apply to Cabinet secretaries or judicial nominees.

The move represents the largest block of confirmations since the rule change took effect. Among those approved were former Republican Senate candidate Herschel Walker, who will serve as ambassador to the Bahamas, and Sergio Gor, former director of the White House Presidential Personnel Office, who will serve as ambassador to India.

 

Republicans invoked the so-called “nuclear option” — a party-line rules change — to speed up the confirmation process after months of Democratic opposition had slowed it to a crawl.

Some Republicans briefly considered allowing President Trump to make recess appointments, which would enable him to fill positions while the Senate was not in session. However, GOP leaders ultimately rejected that idea, citing concerns that it could backfire when their party is next in the minority.

The mass confirmation marks a major victory for Trump as his administration continues to fill key posts across the federal government amid ongoing partisan gridlock.

 

In September, Senate Republicans weighed changes to the chamber’s confirmation process as they faced a backlog of judicial nominations due to stall tactics by minority Democrats.

President Trump had criticized Judiciary Committee Chairman Chuck Grassley (R-Iowa) for preserving the Senate’s “blue slip” tradition, which allowed home-state senators to weigh in on nominees and could effectively block their confirmation if the slips were withheld.

Comments (0)

Loading comments...

Inside Trump’s Bold Health Agency Shake-Up: Reform or Risk for America’s Medical System?
Inside Trump’s Bold Health Agency Shake-Up: Reform or Risk for America’s Medical System? The administrationof Donald Trump has reignited debate in Washington after proposing a sweeping reorganization of America’s federal health agencies. Supporters say the changes would modernize a bloated bureaucracy, while critics warn the restructuring could weaken oversight and disrupt the nation’s public-health infrastructure. At the center of the proposal is a plan to consolidate overlapping offices within the U.S. Department of Health and Human Services. Officials argue the move would reduce redundancy, streamline decision-making, and accelerate responses to national health emergencies. Advocates inside the administration say federal health agencies have grown too complex over decades. They believe merging departments and cutting administrative layers could help government scientists focus on research, disease prevention, and rapid crisis response rather than bureaucratic procedures. However, critics fear the reorganization could weaken specialized institutions such as the Centers for Disease Control and Prevention and the Food and Drug Administration. Public-health experts warn that structural changes might disrupt ongoing programs and slow the nation’s ability to track outbreaks or approve new treatments. Supporters counter that reform is necessary after years of criticism about inefficiency within federal health agencies. Some lawmakers argue that outdated structures make it harder for the government to coordinate research funding and respond quickly to emerging threats. Political reactions have been sharply divided. Several Republican lawmakers praised the proposal as a long-overdue overhaul of government institutions. Many Democrats, meanwhile, questioned whether the changes were driven by policy needs or by broader political goals. Healthcare professionals are also watching closely. Some hospital administrators say clearer chains of command could improve communication during crises, while others worry that reshuffling agencies could create confusion across the healthcare system. Public-health researchers stress that stability is critical for long-term scientific programs. They note that federal health agencies manage complex projects, from vaccine development to disease monitoring, that require consistent leadership and funding over many years. As debate intensifies, the proposal highlights a larger question about the future of American healthcare governance. Whether seen as bold reform or risky disruption, the plan has already triggered one of the most significant discussions about federal health policy in recent years.